Biotech

A Report from BIO-Europe Spring 2017

The blue skies and balmy weather of Barcelona were the perfect backdrop for BIO-Europe Spring this year. The 2,400 biotech pros at the conference...

Report from J.P. Morgan 2017

So, that’s the J.P. Morgan Healthcare Conference done for another year. For just a few highly energised days it felt as if nearly every...

What next for EU and UK biotech boards?

In light of the UK’s decision to leave the EU, it’s worth revisiting our recent Talent Equity® report on what makes successful biotech boards. The question...

Report from JP Morgan 2016

The ‘Salmon Run’ of the Life Sciences is over for another year. Here are some take home messages. Public funding is uncertain but institutional investor coffers are full The withdrawal...